Pfizer Announces Deal To Provide COVID Pill To Low-Income Countries

In an agreement announced on Tuesday, Pfizer will permit its COVID-19 pill treatment to be manufactured and sold in countries that might not be able to otherwise afford the treatment.

The deal includes Pfizer working with Medicines Patent Pool (MPP), “a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income countries.”

Through the agreement, MPP will be able to “facilitate additional production and distribution of the investigational antiviral, pending regulatory authorization or approval, by granting sub-licenses to qualified generic medicine manufacturers, with the goal of facilitating greater access to the global population.”